Xolair Prior Authorization Resources

Find the right PA form for your patient's payer, get the ICD-10 codes you need, and download appeal templates — all in one place.

Blue Cross Blue Shield of Arkansas - Pharmacy Prior Authorization Form Arkansas Blue Cross Blue Shield
Blue Cross of Idaho - General Prior Authorization Form Blue Cross of Idaho Health Services, Inc.
California - Uniform Prior Authorization FormCalifornia
CDPHP - General Prior Authorization FormCapital District Physicians Health Plan, Inc.
Cigna - General Medication Prior Authorization FormCigna Corporation
Cigna - Xolair Prior Authorization Form Cigna Corporation

ICD-10 codes for Xolair Prior Authorizations

J45.9Other and unspecified asthma
J45.901Unspecified asthma with (acute) exacerbation
J32.9Chronic sinusitis, unspecified
Z91.01Food allergy status
L50.9Urticaria, unspecified
L50.1Idiopathic urticaria

Appeal Templates

If the payer denies coverage, these templates help you build a stronger appeal.
Customizable Letter of Medical NecessityPrior authorization and coverage support resources for Xolair. Includes forms, templates, and guidance for insurance approval process.
Tips for Drafting a Letter of Medical NecessityPrior authorization and coverage support resources for Xolair. Includes forms, templates, and guidance for insurance approval process.
Customizable Appeal LetterTemplate letter for appealing insurance denials. Provides structure for presenting clinical evidence and medical necessity for Xolair therapy.
Tips for Drafting an Appeal LetterTemplate letter for appealing insurance denials. Provides structure for presenting clinical evidence and medical necessity for Xolair therapy.
A peer-to-peer review with the payer's medical director can often resolve denials faster than a formal appeal.

Support for Getting Your Patient on Xolair

Check coverage & formulary statusVerify PA requirements for your patient's plan.Find savings programsCopay cards, patient assistance, and more.Check medication interactionsScreen prescriptions for harmful drug combinations.